8-K: EVA Live Launches AI Ad Platform NeuroServe, Nasdaq Listing

EVA Live, Inc. announces the official launch of NeuroServe, its next-generation AI online advertising platform, alongside the approval of its common stock listing on The Nasdaq Capital Market.

Summary

• EVA Live, Inc. has officially launched NeuroServe, an AI-driven online advertising platform designed to enhance campaign performance, reduce inefficiencies, and scale advertising efforts using real-time learning intelligence.
• NeuroServe, developed over two years and BETA tested in 2025, aims to replace manual optimization with instant decision-making, thereby reducing human error and accelerating campaign performance.
• Key benefits include real-time AI-driven optimization, higher-quality traffic and lead generation, improved return on ad spend, and automated optimization for high-volume advertising.
• The global online advertising market was estimated at approximately $500 billion in 2025 and is projected to grow to over $1.3 trillion by the early 2030s, driven by e-commerce, mobile adoption, and AI technologies.
• Management expects NeuroServe to become EVA Live's core revenue-generating product and its leading product by sales by the end of 2026, subject to market conditions and execution.
• The company has expanded its engineering, product, and go-to-market teams to support the platform's scalability.
• EVA Live, Inc. also received approval to list its common stock on The Nasdaq Capital Market, an event announced on January 29, 2026.

Sentiment

Score: 8

Explanation: StockSavvy.ai views this as a highly positive announcement, driven by the launch of a significant AI-driven product in a rapidly growing market and the strategic Nasdaq listing approval, indicating strong future potential.

Positives

• Official launch of NeuroServe, a next-generation AI online advertising platform, after two years of development and successful BETA testing.
• NeuroServe offers significant benefits including real-time AI optimization, reduced manual errors, improved return on ad spend, and higher-quality traffic/lead generation.
• The platform is built for enterprise scale and has been stress-tested to validate performance, stability, and scalability.
• The global online advertising market is substantial ($500 billion in 2025) and projected for significant growth (over $1.3 trillion by early 2030s), providing a large market opportunity.
• Management anticipates NeuroServe will become the core revenue-generating product and the leading product by sales by the end of 2026.
• Expansion of engineering, product, and go-to-market teams to support platform scalability and growth.
• Approval for listing common stock on The Nasdaq Capital Market, enhancing visibility and access to capital markets.

Risks

• The success of NeuroServe and its ability to become the leading product by sales by the end of 2026 is subject to market conditions and execution.
• Forward-looking statements are not guarantees of future performance, and actual results may differ materially due to various factors.

Future Outlook

Management expects NeuroServe to become EVA Live's core revenue-generating product and its leading product by sales by the end of 2026, contingent on favorable market conditions and successful execution. The company anticipates capitalizing on the significant growth projected for the global online advertising market.

Management Comments

• Management expects NeuroServe to represent a growing share of EVA Live's overall revenue and to become the Company's leading product by sales by the end of 2026, subject to market conditions and execution.

Industry Context

StockSavvy.ai notes that EVA Live's launch of NeuroServe aligns strategically with the robust growth trajectory of the global online advertising market, which is projected to more than double by the early 2030s. The platform's focus on AI-driven optimization positions the company to capitalize on increasing demand for efficient and scalable digital marketing solutions, a trend accelerated by e-commerce expansion and mobile adoption.

Comparison to Industry Standards

• The filing highlights the global online advertising market's estimated size of $500 billion in 2025, projected to grow to over $1.3 trillion by the early 2030s, according to Grand View Research.
• The filing does not provide specific comparisons of NeuroServe's performance metrics or market share against direct competitors like Google Ads, Meta Ads, or other programmatic advertising platforms.

Stakeholder Impact

• Shareholders: Potential for increased stock value due to new product revenue, market growth, and enhanced visibility from Nasdaq listing.
• Customers (Advertisers): Access to an AI-driven platform promising improved ad performance, reduced inefficiencies, and higher return on ad spend.
• Employees: Expanded engineering, product, and go-to-market teams indicate growth opportunities and increased workforce.

Next Steps

• NeuroServe is now available to online businesses.
• Live demonstrations of NeuroServe can be requested through EVA Live's website at eva.live/nueroserve.
• Management expects NeuroServe to become the Company's leading product by sales by the end of 2026.

Key Dates

Recommendation

The launch of NeuroServe, an advanced AI-driven advertising platform, positions EVA Live in a rapidly expanding global online advertising market projected for substantial growth. Coupled with the strategic approval for Nasdaq listing, this announcement signals strong operational momentum and increased market visibility. Management's confident outlook for NeuroServe to become the primary revenue driver by the end of 2026 suggests significant upside potential for investors.

Keywords

AI, digital advertising, online advertising, ad tech, NeuroServe, EVA Live, Nasdaq, GOAI, marketing technology, real-time optimization